Page 3 - Pharma

Dr Reddy's launches bivalirudin injection in US

Bivalirudin, a direct thrombin inhibitor, is used to prevent blood clots in people

AstraZeneca sells antacid brand Neksium to Pfizer India for Rs 75 cr

Deal to help Pfizer, which also owns Gelusil brand, strengthen its presence in gastrointestinal area

JSR Corp arm KBI Biopharma to invest $ 30 mn to expand two facilities in US

It will expand biopharmaceutical manufacturing capacity at both its Durham and Boulder facilities

PET scanner: Aiding innovations in diagnostics and treatment of cancers

Positron emission tomography (PET) scanning has vastly improved the results of cancer diagnosis

Lyka Labs inks out-licensing deal with US-based generics firm

The market size of the licensed formulations is about $ 1.4 bn as per IMS March 2017, says Lyka

AIIMS hospital in Assam receives Cabinet nod

To be set up under the Pradhan Mantri Swasthya Suraksha Yojana & involve Rs 1,123 cr investment

VLCC forays into nutraceuticals by acquiring Wellscience business

Extends its presence in the high-growth FMHG segment through nutraceuticals & direct selling

Glenmark receives US FDA approval for hypertension drug nebivolol

It is also eligible for 180 days exclusivity for the drug, a generic version of Forest's Bystolic

Govt to set up cancer institutes each costing Rs 100 cr: Anupriya Patel

Govt has already approved a scheme for enhancing the tertiary care cancer facilities in the country

US FDA accepts application of Sun Pharma's partner Merck for tildrakizumab

Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis

Vaccines may be the way forward for malaria eradication in India

Dr Dharminder Nagar offers 5-point agenda to take immunisation programmes in India to the next level

Avery Dennison buys Finesse Medical to strengthen healthcare materials biz

Finesse Medical makes healthcare products used in the management of wound care and skin conditions

Dr Reddy's Labs receives US FDA nod for doxorubicin injection

DRL had partnered with Natco Pharma Ltd for developing the product, a generic version of Doxil

Biogen buys Remedy Pharmaceuticals' stroke drug Cirara

Biogen will pay $120 mn upfront payment plus potential milestone and royalty payments

Thermo Fisher Scientific buys Patheon for $7.2 billion

Patheon will facilitate Thermo Fisher's entry into the high-growth $40-billion CDMO market

Lupin receives CDSCO's approval for anti-allergic drug bepotastine

According to IMS, the market for plain antihistamines in India is estimated at about Rs 860 crs

Vivimed Labs & Strides Shasun to form two JVs to tap US generic market

While JV in India will own US FDA-approved plant in Alathur, Singaporean JV will own certain ANDAs

Germany's Merck & Stelis Biopharma open bioprocess scale-up lab in India

Lab, based at Bengaluru, provides end-to-end solutions from bioprocess development to manufacturing

Diagnostics in India: Full-throttle growth expected in the near future

Govt's universal health plan is expected to cost an estimated Rs 1.6 trillion over the next 4 years

US Court rules in favour of Zydus in ulcerative colitis drug patent case

It ruled that Zydus' generic version of Lialda (mesalamine) does not infringe patent of Shire